REFERENCES
- Mahendradas P, Kawali A, Bharti N, et al. The clinical spectrum of Vogt-Koyanagi-Harada syndrome: a single-center experience from South India. Int J Rheumatol Clin Immunol. 2013;26:1.
- Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye. 2013;27:787–794. doi:10.1038/eye.2013.107.
- Gonzaga Garay-Aramburu MD, Gomez-Moreno A. Choroidal detachment due to hypotony after intravitreal injection of dexamethasone implant. JAMA Ophthalmol. 2013;131:1.
- Ranjan R, Agarwal M. Rebound inflammation after an intravitreal injection in Vogt-Koyanagi-Harada syndrome. Ind J Ophthalmol. 2018;66:863–865. doi:10.4103/ijo.IJO_1145_17.
- Harada Y, Bhat P, Munk MR, Goldstein DA. Changes in scleral architecture in chronic Vogt–Koyanagi–Harada disease. Ocul Immunol Inflamm. 2017;25:85–92.